I don't think we need another law on the books to cover that subject.

217

I think the primary value of this legislation is that it demonstrates Maryland's commitment to continue being a player in cutting-edge science.

204

We are growing significantly faster than the industry as a whole.

155

Novel technologies for delivering ... vaccines can certainly find a market if they are more effective, less costly, less invasive or more convenient to use than the alternatives.

123